Graves Kurt

Avg. Two Year Performance

54% Avg. Purchase Return
24% Compound
(30%) Avg. Sale Return
(14%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%(19%)5%9%54%
Purchase Success Rate1 of 10 of 11 of 11 of 11 of 1
Average Sale Return(2%)(< 1%)(4%)(< 1%)(30%)
Sale Success Rate4 of 83 of 82 of 82 of 81 of 8
Drugs » Drug Manufacturers - Other

EVP, Chief Commercial Officer:

Holdings: 60.48K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 11.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--